You are here

  • Home
  • Archive
  • Volume 4, Issue 2
  • Intensive geriatric rehabilitation reduced hospital stay and time to independent living in hip fracture patients with mild to moderate dementia

Article Text

Article menu
Download PDFPDF
Treatment
Intensive geriatric rehabilitation reduced hospital stay and time to independent living in hip fracture patients with mild to moderate dementia

https://doi.org/10.1136/ebn.4.2.54

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Huusko TM, Karppi P, Avikainen V, et al.Randomised, clinically controlled trial of intensive geriatric rehabilitation in patients with hip fracture: subgroup analysis of patients with dementia.BMJ2000 Nov 4;321:1107–11OpenUrlAbstract/FREE Full Text

    QUESTION: In hip fracture patients with dementia, is intensive geriatric rehabilitation (IGR) effective and does its effectiveness vary with degree of dementia?

    Design

    Preplanned subgroup analysis of a randomised (unclear allocation concealment), unblinded, controlled trial with 1 year of follow up.

    Setting

    Jyväskylä Central Hospital, Finland.

    Patients

    260 independently living patients ≥65 years of age (mean age 80 y, 72% women) who were admitted to hospital with a hip fracture. Exclusion criteria were inability to walk unaided before the fracture, pathological fractures, multiple fractures, serious early complications, receiving calcitonin treatment, or terminal illness. 238 patients (92%) completed the study.

    Intervention

    After surgery for hip fracture, 130 patients were allocated to IGR, which consisted of providing advice, training, drug treatment, physiotherapy, occupational …

    View Full Text

    Footnotes

    • Sources of funding: Central Finland Healthcare District; Kuopio University Hospital; Emil Aaltonen Foundation; Uulo Arhio Foundation; Novartis Finland.

    • For correspondence: Dr T M Huusko, Department of Public Health and General Practice, University of Kuopio, PO Box 1627, 70211 Kuopio, Finland.